360 Participants Needed

Women SHINE Intervention for HIV/AIDS

JK
AF
CC
Overseen ByCassandra Cyr, MPH
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University of California, San Diego
Must be taking: ART
Stay on Your Current MedsYou can continue your current medications while participating

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a program called Women SHINE, designed to assist women with HIV/AIDS who have experienced violence and struggle with medication adherence. The study will compare two groups: one receiving Women SHINE support and the other receiving basic self-care resources (control group). Women with HIV who have experienced violence as adults and find it difficult to consistently take their medication might be suitable candidates. The goal is to determine if Women SHINE can improve medication adherence and emotional health. As an unphased trial, this study offers participants a unique opportunity to contribute to research that could enhance support systems for women facing similar challenges.

Will I have to stop taking my current medications?

The trial does not specify whether you need to stop taking your current medications. However, since participants must be currently prescribed ART (HIV medication), it seems you should continue taking it.

What prior data suggests that the Women SHINE intervention is safe?

Research shows that trauma-informed programs like Women SHINE are generally well-received. These programs provide peer support and education to assist women with HIV/AIDS who have experienced interpersonal violence.

Previous studies on similar programs have shown improvements in mental health and social support without major safety issues. Participants often report feeling better and developing stronger coping skills. Significant negative effects from these programs have not been reported.

Overall, evidence suggests that the Women SHINE program is safe, enhancing emotional and social support without introducing physical or medical risks.12345

Why are researchers excited about this trial?

Researchers are excited about the Women SHINE intervention because it offers a holistic and peer-supported approach to addressing HIV/AIDS in women, setting it apart from traditional medical treatments. Unlike standard care, which often focuses solely on medication, Women SHINE includes a combination of video-based one-on-one peer navigation and weekly psycho-education support group sessions. This method emphasizes mental health, interpersonal violence, and substance use alongside HIV care, providing a comprehensive support system. The integration of peer navigators who share similar experiences with participants adds a unique layer of relatability and support, potentially leading to improved health outcomes and empowerment for women living with HIV/AIDS.

What evidence suggests that this trial's treatments could be effective for women living with HIV/AIDS?

Research has shown that the Women SHINE program, a treatment in this trial, might assist women with HIV/AIDS who have experienced violence and struggle with medication adherence. Women in similar programs have improved their adherence to antiretroviral therapy (ART), crucial for controlling the virus. The Women SHINE intervention provides personalized support from peer supporters and group therapy sessions, enhancing emotional health and coping skills. This support can significantly help women maintain medication consistency and improve overall health. Early signs suggest this approach may improve both mental health and medication habits.16789

Who Is on the Research Team?

JK

Jamila K Stockman, PhD, MPH

Principal Investigator

University of California, San Diego

Are You a Good Fit for This Trial?

This trial is for cisgender women over 18 living with HIV/AIDS who have experienced interpersonal violence as adults and are not fully adherent to their antiretroviral therapy (ART). Participants must speak English or Spanish, have internet access, and cannot be involved in another adherence intervention.

Inclusion Criteria

Self-report of <90% past-month ART adherence
Access to an internet browser
I identify as a cisgender female.
See 5 more

Exclusion Criteria

No access to an internet browser
I am a transgender female.
I am under 18 years old.
See 9 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Women SHINE intervention arm receives a four-month program including video-based peer navigation support, 7 weekly psychoeducation support group sessions, and access to a static website with resources.

16 weeks
Weekly sessions (virtual)

Control

Control arm receives one 60-minute group session on self-care and well-being and access to a static website with resources.

1 week
1 session (virtual)

Follow-up

Participants are monitored for improvements in ART adherence, PTSD symptoms, and emotion regulation at 4-, 8-, and 12-months post-randomization.

12 months
Assessments at 4, 8, and 12 months (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Control
  • Women SHINE
Trial Overview The study compares the Women SHINE web-based peer support program against a control group. The Women SHINE group receives one-on-one sessions, check-ins, support groups with therapists, and resource access. The control gets a single self-care session and similar resources.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Women SHINEExperimental Treatment1 Intervention
Group II: Control ArmPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Diego

Lead Sponsor

Trials
1,215
Recruited
1,593,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Published Research Related to This Trial

The study will evaluate the effectiveness of the ImpACT+ intervention, a trauma-focused coping strategy, in promoting viral suppression and ART adherence among 350 women living with HIV initiating treatment in South Africa.
By addressing the mental health impacts of sexual trauma, the ImpACT+ intervention aims to improve clinical outcomes and overall well-being for women, potentially leading to significant benefits for communities in sub-Saharan Africa.
ImpACT+, a coping intervention to improve clinical outcomes for women living with HIV and sexual trauma in South Africa: study protocol for a randomized controlled trial.Sikkema, KJ., Rabie, S., King, A., et al.[2023]
Peer navigation significantly improves the quality of HIV care for female sex workers (FSWs), as evidenced by a study of 211 participants in the Dominican Republic, where 41.2% reported contact with a peer navigator in the last 6 months.
FSWs who engaged with peer navigators experienced more respectful treatment from clinic staff and reported greater satisfaction with their overall HIV care services, highlighting the importance of peer support in enhancing healthcare experiences.
Exploring peer navigation and support in the quality of HIV care experiences of female sex workers in the Dominican Republic.Karver, TS., Barrington, C., Donastorg, Y., et al.[2022]
The 'Salud y Orgullo Mexicano' (SOM) intervention was specifically designed to improve HIV care linkage and retention for Mexican men who have sex with men (MSM) in Chicago, utilizing community input and a modified intervention mapping process.
The development of SOM involved combining elements from existing interventions and refining them based on feedback from the target community, with plans for future implementation and evaluation to assess its effectiveness.
Salud y Orgullo Mexicano: Development of a Culturally Specific Transnational Linkage and Retention in Care Intervention for Mexican Men Who Have Sex with Men Living with HIV in Chicago.Johnson, AK., Buenrostro, R., Soberanis, G., et al.[2021]

Citations

Women SHINE: Addressing Syndemics and HIV Among ...In the US, women living with HIV/AIDS (WLHA) are less likely to be adherent to antiretroviral therapy (ART) and virally suppressed compared to men living with ...
Women SHINE Intervention for HIV/AIDSThis trial is for cisgender women over 18 living with HIV/AIDS who have experienced interpersonal violence as adults and are not fully adherent to their ...
Women SHINE: Addressing Syndemics and HIV Among ...In the US, women living with HIV/AIDS (WLHA) are less likely to be adherent to antiretroviral therapy (ART) and virally suppressed compared to ...
4.istriveresearchlab.comistriveresearchlab.com/womenshine/
Women SHINEWomen SHINE is a randomized controlled trial that aims to improve antiretroviral therapy (ART) adherence among women living with HIV/AIDS (WLHA)
5.womenshinestudy.comwomenshinestudy.com/about-2/
About - Women SHINEWomen SHINE is a web-based peer navigation intervention to help cisgender women living with HIV/AIDS improve their HIV care and mental well-being.
LinkPositively: A Trauma-Informed Peer Navigation and Social ...Abstract. In the U.S., Black women living with HIV/AIDS (WLHA) are affected disproportionately by interpersonal violence, which often co-occurs with adverse ...
A Trauma-Informed HIV Intervention (LinkPositively) to ...The substance use, violence, and HIV/AIDS syndemic is the overlapping and synergistic intersection of these conditions [ ...
A Trauma-Informed HIV Intervention (LinkPositively) to ...The substance use, violence, and HIV/AIDS syndemic is the overlapping and synergistic intersection of these conditions [5]; in addition, mental ...
Exploring the Impact of an Integrated Trauma-Informed HIV ...An Expressive Therapy Group Disclosure Intervention for Women Living with HIV Improves Social Support, Self-Efficacy, and the Safety and Quality of ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security